Emcure Pharma Q4 Results: Stock rises 8% after net profit grows 64% from last year

Shares of Emcure Pharmaceuticals Ltd. gained as much as 8% on Thursday, May 22, after the company’s fourth quarter results.

The company’s net profit for the quarter surged 64% year-on-year to ₹189 crore, compared to a profit of ₹115 crore during the same quarter last year.

Revenue for the period also rose on a year-on-year basis to ₹2,116 crore from ₹1,771 crore, implying a 20% growth.
The board recommended a final dividend of ₹3 per equity share of face value of ₹10 each (at the rate of 30%) for the financial year ended March 31, 2025.

This will be subject to approval of the members of the company at the ensuing Annual General Meeting of the company. The dividend, once approved, will be paid within the prescribed timeline under the Companies Act, 2013.

Shares of Emcure Pharmaceuticals Ltd are trading 8.14% higher after the results announcement at ₹1,161. Despite today’s gain, the stock is down 21% so far in 2025.